Patent Thickets Constrain US Biosimilars Market

Patent Thickets Constrain US Biosimilars Market

Patent Thickets Constrain US Biosimilars Market Alex Brill and Christy Robinson | BioProcess International Biosimilars represent a significant cost-savings opportunity in the United States because they can introduce competition for some of the most expensive and...
Alex Brill Interviewed on Future of US Biosimilars Market

Alex Brill Interviewed on Future of US Biosimilars Market

Alex Brill Interviewed on Future of US Biosimilars Market In a new BioWorld article, Mari Serebrov discusses efforts by Congress to control US prescription drug prices. Interviewed for the article was MGA’s Alex Brill, who talks about the potential side effects...